title: The safety of laparoscopic sleeve gastrectomy among diabetic patients.
abstract: Laparoscopic sleeve gastrectomy (LSG) is a commonly performed bariatric procedure. Although bariatric surgery is becoming increasingly recognized as a treatment option for diabetes, there remain concerns about the operative risks faced by diabetic patients. This study's objective was to determine the safety of bariatric surgery in diabetic patients, specifically the type 2 diabetic (T2DM) population.
  
  
  
  Patients over 18 years of age with a body mass index (BMI) ≥ 35 kg/m2who underwent LSG in 2012 in the ACS-NSQIP database were identified. Emergency cases were excluded from analysis. Data included patient demographics, comorbidities, length of stay, and 30-day complications. The primary outcome was 30-day overall complication rate, and secondary outcomes included major complications and reoperation rates.
  
  
  
  There were 6399 LSG in the NSQIP database in 2012. Three hundred and twenty-two patients were excluded for BMI < 35, and 15 cases were deemed emergencies and excluded. Of the 6062 LSG who met the study criteria, 4726 (78 %) of patients were non-diabetic, 941 (15.5 %) had T2DM, and 395 (6.5 %) had T1DM. T2DM patients were more likely to be male (28.9 vs. 19.3 %, p < 0.001), were older (47.6 years vs. 42.5 years, p < 0.001), and had a higher BMI (46.4 vs. 45.7 kg/m2, p = 0.027) compared with non-diabetics. The overall 30-day complication rate did not differ between groups (6.5 % T2DM vs. 5.6 % non-diabetic, p = 0.292). After controlling for possible confounders, T2DM remained at no increased risk of 30-day complications (OR 1.16, 95 % CI 0.87-1.55, p = 0.301). In sub-analyses of specific complications, T2DM had a slightly higher rate of blood transfusions (1.8 vs. 1.0 %, p = 0.037). Other postoperative complications did not differ between groups. The 30-day complication rate for type 1 diabetics was greater than for T2DM (9.9 vs. 6.5 %, p = 0.031) and non-diabetics (9.9 vs. 5.6 %, p < 0.001).
  
  
  
  Laparoscopic sleeve gastrectomy is a safe procedure for type 2 diabetics with regard to early postoperative complications.
authors: Department of General Surgery, NYU Langone Medical Center, 550 1st Avenue, #15N1, New York, NY, 10016, USA. Collin.creange@nyumc.org.
authors: Collin
authors: C
authors: Creange
authors: Department of General Surgery, NYU Langone Medical Center, 550 1st Avenue, #15N1, New York, NY, 10016, USA.
authors: Monica
authors: M
authors: Sethi
authors: Department of Bariatric Surgery, NYU Langone Medical Center, 530 1st Avenue, Suite 10s, New York, NY, 10016, USA.
authors: George
authors: G
authors: Fielding
authors: Department of Bariatric Surgery, NYU Langone Medical Center, 530 1st Avenue, Suite 10s, New York, NY, 10016, USA.
authors: Christine
authors: C
authors: Ren-Fielding
mesh_terms: D000328:Adult; D050110:Bariatric Surgery / Q000379:methods*; D015897:Comorbidity; D016208:Databases, Factual; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology*; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology*; D005260:Female; D005743:Gastrectomy / Q000379:methods*; D006801:Humans; D010535:Laparoscopy / Q000379:methods*; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000453:epidemiology / Q000601:surgery*; D011183:Postoperative Complications / Q000453:epidemiology*; D011184:Postoperative Period; D012086:Reoperation; D012189:Retrospective Studies; D012449:Safety; D016896:Treatment Outcome; D015431:Weight Loss
keywords: Bariatric; Diabetes; Gastrectomy; Laparoscopic; Non-Insulin; Sleeve